On 12 September, the BioMed Alliance is joining a number of stakeholders for an event on Brexit and the European Parliament’s role in prioritising patients, public health and health security across Europe. At a critical time when there is a very strong risk of a no-deal scenario, the big questions concerning Brexit for patients across the whole EU remain unanswered. This event will focus on explaining to new MEPS the challenges of safeguarding public health and health security. It will also highlight what the European Parliament can do to follow up on its resolution from 14 March 2018 to ensure that the new European Commission is aware of the challenges and is acting to mitigate the risks.
DRAFT AGENDA
| Time | Speaker and Subject |
| 10:00-10:05 | Introduction and welcome |
| 10:05-10:20 | Usman Khan, Executive Director European Patient’s Forum - key concerns for European patients |
| 10:20-10:35 | Professor George Griffin, President, Federation of European Academies of Medicine– safeguarding European medical research post Brexit |
| 10:35-10:50 | Fiona Godfrey, Secretary General, European Public Health Alliance, preserving public health |
| 10:50-11:05 | David Boyd, Astrazeneca, access to and safety of medicines and medical devices |
| 11:05-11:20 | Pascal Garel, Secretary General, European Hospital and Healthcare Federation, challenges facing European hospitals |
| 11:20-11:40 | Question and Answers |
| 11:40-11:50 | Concluding remarks |
The event takes place on Thursday 12 September from 10.00-12.00 in the European Parliament, Room A3G2. Registration: https://forms.gle/6HWVZ7wBGpfQk2Wt7
For more information, read our Briefing on the consequences of Brexit on health and health research here: Download